SEC Form 4 · accession 0000950103-16-014473
CASI Pharmaceuticals, Inc. · CASI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Fei Yang
10% Owner
SPARKLE BYTE LTD
10% Owner
SNOW MOON LTD
10% Owner
Jianguang Li
10% Owner
Suyang Zhang
10% Owner
Dongliang Lin
10% Owner
Hugo Shong
10% Owner
Period of report
Jun 24, 2016
Accepted (ET)
Jun 29, 2016 · 9:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000895051
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F1 | Jun 24, 2016 | P | 3,753,855 | $1.19 | A | 8,498,765 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WarrantF2,F1 | $1.69 | Jun 24, 2016 | P | 750,771 | A | Sep 23, 2016 | Sep 23, 2019 | Common Stock | 750,771 | 1,699,753 | D |
Explanation of responses
- F1These securities are directly owned by Sparkle Byte Limited ("Sparkle Byte") and may be deemed to be indirectly beneficially owned by the other reporting persons. Snow Moon Limited ("Snow Moon") holds 100% of the equity interest of Sparkle Byte. Tianjin Jingran Management Center (Limited Partnership) ("Tianjin Jingran") holds 100% of the equity interest of Snow Moon. He Xie Ai Qi Investment Management (Beijing) Co., Ltd. ("He Xie Ai Qi") is the general partner of Tianjin Jingran. Jianguang Li, Dongliang Lin, Fei Yang and Suyang Zhang each holds 25% of the equity interest of He Xie Ai Qi. Jianguang Li, Dongliang Lin and Hugo Shong are the directors of He Xie Ai Qi. The filing of this statement by the reporting persons shall not be deemed an admission that such persons are, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this statement.
- F2The shares of common stock and the warrants were issued in units consisting of one share of common stock and a warrant to purchase 0.2 shares of common stock. The purchase price for one share was $1.190 and the purchase price for a warrant to purchase 0.2 shares of common stock is $0.025.The filing of this statement by the reporting persons shall not be deemed an admission that such persons are, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this statement.